UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

HER2-low gastric cancer: is the subgroup targetable?

ESMO open, 2024-09, Vol.9 (9), p.103679, Article 103679

2024

Volltextzugriff (PDF)

A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care

ESMO open, 2021-10, Vol.6 (5), p.100234-100234, Article 100234

2021

Volltextzugriff (PDF)

LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response

The Journal of immunology (1950), 2000-04, Vol.164 (8), p.4105-4110

2000

Volltextzugriff (PDF)

Correction to: Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018

The oncologist (Dayton, Ohio), 2022-08, Vol.27 (8), p.e685-e685

2022

Volltextzugriff (PDF)

Life-threatening intratumoral hemorrhage in plexiform neurofibroma: A case report

JPRAS open, 2015-09, Vol.5 (C), p.24-28

2015

Volltextzugriff (PDF)

P-33 Prognostic impact of single organ pulmonary metastasis in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors as second-line chemotherapy

Annals of oncology, 2022-06, Vol.33, p.S258-S259

2022

Volltextzugriff (PDF)

P-34 Does the chemotherapeutic efficacy of trifluridine/tipiracil plus bevacizumab change depend on pre-treatment vascular endothelial growth factor inhibitors?

Annals of oncology, 2022-06, Vol.33, p.S259

2022

Volltextzugriff (PDF)

1649P Comprehensive genomic profiling contributes to the prognosis of patients with advanced pancreatic cancer

Annals of oncology, 2023-10, Vol.34, p.S910-S910

2023

Volltextzugriff (PDF)

Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors

Cancer management and research, 2020-01, Vol.12, p.4585-4593, Article 4585

2020

Volltextzugriff (PDF)

1391P Clinical progress in inoperable or recurrent advanced gastric cancer treatment from 1,004 single institute experiences between 2007 and 2018

Annals of oncology, 2021-09, Vol.32, p.S1053-S1053

2021

Volltextzugriff (PDF)

1426P The utility of the prognostic index for practicing the continuum of care in advanced gastric cancer: The suitability assessment and modification of the JCOG prognostic index in real-world data

Annals of oncology, 2021-09, Vol.32, p.S1067-S1068

2021

Volltextzugriff (PDF)

126P Late line FOLFOX therapy after prior cisplatin-based regimen in advanced esophageal squamous cell carcinoma: A multi-institutional retrospective study

Annals of oncology, 2022-11, Vol.33, p.S1481-S1481

2022

Volltextzugriff (PDF)

389P Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST)

Annals of oncology, 2022-09, Vol.33, p.S715

2022

Volltextzugriff (PDF)

P-80 Analysis of plasma angiogenesis factors on the efficacy of FOLFIRI plus ramucirumab and FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer from WJOG9216G randomized phase II study

Annals of oncology, 2023-06, Vol.34, p.S42-S42

2023

Volltextzugriff (PDF)

Real-world outcomes of trifluridine/tipiracil for heavily pretreated patients with advanced gastric cancer

ESMO Gastrointestinal Oncology, 2024-03, Vol.3, p.100046, Article 100046

2024

Volltextzugriff (PDF)

Primary results of multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII)

Annals of oncology, 2019-10, Vol.30, p.v302-v303

2019

Volltextzugriff (PDF)

786P - Primary results of multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII)

Annals of oncology, 2019-10, Vol.30, p.v302-v303

2019

Volltextzugriff (PDF)

Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures

Development (Cambridge), 2003-06, Vol.130 (11), p.2505-2512

2003

Volltextzugriff (PDF)

Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis

ESMO Gastrointestinal Oncology, 2024-09, Vol.5, p.100072, Article 100072

2024

Volltextzugriff (PDF)

Thoracic spondylolisthesis and spinal cord compression in diffuse idiopathic skeletal hyperostosis: a case report

Journal of medical case reports, 2017-04, Vol.11 (1), p.90-90, Article 90

2017

Volltextzugriff (PDF)

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

Nature medicine, 2000-03, Vol.6 (3), p.283-289

2000

Volltextzugriff (PDF)

Stage‐ and site‐specific DNA demethylation during neural cell development from embryonic stem cells

Journal of neurochemistry, 2005-04, Vol.93 (2), p.432-439

2005

Volltextzugriff (PDF)

Involvement of STAT3 in the Granulocyte Colony-stimulating Factor-induced Differentiation of Myeloid Cells

The Journal of biological chemistry, 1997-10, Vol.272 (40), p.25184-25189

1997

Volltextzugriff (PDF)

Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcers

Wound repair and regeneration, 2016-09, Vol.24 (5), p.894-903

2016

Volltextzugriff (PDF)

786PPrimary results of multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(65)
Tagungsberichte
(1)

Sprache

Englisch
(61)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

HER2-low gastric cancer: is the subgroup targetable?

A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care

LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response

Correction to: Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018

Life-threatening intratumoral hemorrhage in plexiform neurofibroma: A case report

P-33 Prognostic impact of single organ pulmonary metastasis in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors as second-line chemotherapy

P-34 Does the chemotherapeutic efficacy of trifluridine/tipiracil plus bevacizumab change depend on pre-treatment vascular endothelial growth factor inhibitors?

1649P Comprehensive genomic profiling contributes to the prognosis of patients with advanced pancreatic cancer

Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors

1391P Clinical progress in inoperable or recurrent advanced gastric cancer treatment from 1,004 single institute experiences between 2007 and 2018

1426P The utility of the prognostic index for practicing the continuum of care in advanced gastric cancer: The suitability assessment and modification of the JCOG prognostic index in real-world data

126P Late line FOLFOX therapy after prior cisplatin-based regimen in advanced esophageal squamous cell carcinoma: A multi-institutional retrospective study

389P Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST)

P-80 Analysis of plasma angiogenesis factors on the efficacy of FOLFIRI plus ramucirumab and FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer from WJOG9216G randomized phase II study

Real-world outcomes of trifluridine/tipiracil for heavily pretreated patients with advanced gastric cancer

Primary results of multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII)

786P - Primary results of multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII)

Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures

Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis

Thoracic spondylolisthesis and spinal cord compression in diffuse idiopathic skeletal hyperostosis: a case report

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

Stage‐ and site‐specific DNA demethylation during neural cell development from embryonic stem cells

Involvement of STAT3 in the Granulocyte Colony-stimulating Factor-induced Differentiation of Myeloid Cells

Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcers

786PPrimary results of multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII)

Suchergebnisse filtern